Key Points• Hif-2a-dependent signaling is dispensable for steady-state multilineage hematopoiesis.• Hif-2a is not essential for HSC self-renewal.Local hypoxia in hematopoietic stem cell (HSC) niches is thought to regulate HSC functions. Hypoxia-inducible factor-1 (Hif-1) and Hif-2 are key mediators of cellular responses to hypoxia. Although oxygen-regulated a-subunits of Hifs, namely Hif-1a and Hif-2a, are closely related, they play overlapping and also distinct functions in nonhematopoietic tissues. Although Hif-1a-deficient HSCs lose their activity on serial transplantation, the role for Hif-2a in cell-autonomous HSC maintenance remains unknown. Here, we demonstrate that constitutive or inducible hematopoiesis-specific Hif-2a deletion does not affect HSC numbers and steady-state hematopoiesis. Furthermore, using serial transplantations and 5-fluorouracil treatment, we demonstrate that HSCs do not require Hif-2a to self-renew and recover after hematopoietic injury. Finally, we show that Hif-1a deletion has no major impact on steady-state maintenance of Hif2a-deficient HSCs and their ability to repopulate primary recipients, indicating that Hif-1a expression does not account for normal behavior of Hif-2a-deficient HSCs. (Blood. 2013;122(10):1741-1745
Vukovic et al. report that Hif-1α and Hif-2α are not required for leukemia stem cell maintenance and AML propagation, but they act synergistically to suppress leukemia development in mice. Furthermore, knockout of HIF-2α or pharmacological inhibition of the HIF pathway in human AML cells has no impact on their survival and proliferation under hypoxic conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.